Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...

Under the newly announced arrangement, Ro will prescribe single-dose vials of Zepbound through its online platform that Lilly will fill through LillyDirect, Lilly’s mail-order pharmacy.

Direct-to-consumer health and wellness company Ro will now offer access to lower-priced, single-dose vials of weight loss drug Zepbound through a new partnership with Eli Lilly.

Eli Lilly strikes Zepbound deal with the telehealth platform Ro, amid questions about future of compounded GLP-1s.

Direct-to-consumer health-care startup Ro said its platform will now offer more affordable single-dose vials of the weight loss drug Zepbound through a new partnership with Eli Lilly.

Telehealth firm Ro will offer low-cost, single-dose vials of Lilly's obesity drug Zepbound, the first alternative to the new LillyDirect DTC channel.

Ro is a telehealth company. To get Zepbound from Ro, you must join the company’s Body Program. This program offers prescription weight loss drugs, coaching and ongoing support, and an insurance ...

Ro offers an online weight loss program that combines on-demand coaching with weight loss medications, including Zepbound. To get started, you first complete an online health questionnaire.

Our goal is to break down barriers and provide patients with safe and effective options they can rely on." In the same press release, Reitano added, “Lilly's release of Zepbound single-dose vials at a ...

Eli Lilly will partner only with telehealth firms that agree to stop selling compound versions of its drug Zepbound or Novo Nordisk’s Wegovy, a move that sidelines Hims & Hers Health, Bloomberg ...